Citations

Showing 10 of 108162 citations.

Individualized Ablation of Hepatocellular Carcinoma: Tailored Approaches across the Phenotype Spectrum
Devcic, Zlatko , Vidal, Lucas Lauar Cortizo , Mody, Kabir , Harnois, Denise M. , Toskich, Beau , Elboraey, Mohamed, Vidal, Lucas, Harnois, Denise, Toskich, Beau B. , Elboraey, Mohamed, Patel, Tushar

Mayo Clinic

Seminars in Interventional Radiology | October 31, 2019 | Volume: 36 | Issue: 04 | Pages: 287-297

10.1055/s-0039-1698755 | PMID 31680719 Get It

AbstractAblation is now recommended by international guidelines for the definitive treatment of hepatocellular carcinoma (HCC). Extensive clinical studies have demonstrated outcomes comparable to surgical resection with shorter hospital stays, decreased costs, and improved quality of life. Successful ablation requires complete treatment of both tumor and margin while preserving critical adjacent structures. HCC exhibits highly variable presentations in both anatomic involvement and biology which have significant implications on choice of ablative therapy. There are now abundant ablation modalities and adjunctive techniques which can be used to individualize ablation and maximize curative results. This article provides a patient-centered summary of approaches to HCC ablation in the context of patient performance, hepatic reserve, tumor phenotype and biology, intra- and extrahepatic anatomy, and ablation technology.
From trends to transformation: where cardio-oncology is to make a difference
Herrmann, Joerg

Mayo Clinic

European Heart Journal | October 31, 2019 | Volume: 40 | Issue: 48 | Pages: 3898-3900

10.1093/eurheartj/ehz781 | PMID 31761931 Get It

The effect of topical epinephrine 1:1000 with and without infiltration of 1% lidocaine with epinephrine 1:100,000 on endoscopic surgical field visualization: a double‐blind randomized controlled study
Tangbumrungtham, Navarat , Hwang, Peter H. , Maul, Ximena, Borchard, Nicole A. , Dholakia, Sachi S. , Patel, Zara M. , Choby, Garret , Patel, Zara , Hwang, Peter H , Nayak, Jayakar V. , Choby, Garret

Mayo Clinic

International Forum of Allergy & Rhinology | October 31, 2019 | Volume: 10 | Issue: 2 | Pages: 147-152

10.1002/alr.22468 | PMID 31671251 Get It

BackgroundThe objective of this study is to determine whether the infiltration of 1% lidocaine with 1:100,000 epinephrine in addition to topical application of 1:1000 epinephrine significantly improves surgical field grading scale score over topical 1:1000 epinephrine alone.MethodsA prospective, double‐blind, randomized, controlled study was performed of 40 patients undergoing bilateral endoscopic sinus surgery (ESS) for chronic rhinosinusitis (CRS). Patients were enrolled and randomly assigned to receive infiltration with 1% lidocaine with 1:100,000 epinephrine on 1 side of the nasal cavity vs plain saline on the other side in preparation for ESS. Both groups received topical application of 1:1000 epinephrine. Surgical videos were recorded and Wormald surgical field grading scale was assigned by 2 blinded reviewers. The number of extra 1:1000 epinephrine pledgets used during the surgery, estimated blood loss, and surgical duration were also recorded.ResultsThere were no statistically significant differences in Wormald surgical field grading scale, number of extra pledgets used, or estimated blood loss between the nasal cavity side infiltrated with 1% lidocaine with 1:100,000 epinephrine in comparison to infiltration with saline. The side infiltrated with 1% lidocaine with 1:100,000 epinephrine had a reduced operative time compared to the side infiltrated with saline (p = 0.002). There were no differences in postoperative bleeding from questionnaire completed by patient at the first postoperative visit.ConclusionAddition of infiltration of 1% lidocaine with epinephrine 1:100,000 to topical application of epinephrine 1:1000 for preparation of ESS does not significantly improve surgical field of view compared to topical epinephrine alone.
Associations between hematology/oncology fellows’ training and mentorship experiences and hematology-only career plans
Masselink, Leah E. , Erikson, Clese , Connell, Nathan T. , Castro, Laura M. De , Dent, Georgette A. , Marshall, Ariela L. , Naik, Rakhi P. , Nelson, Marquita , Rajasekhar, Anita, Sharma, Deva , Smith, Melody , Lee, Alfred Ian , Marshall, Ariela , Smith, Melody , O'Connell, Casey Lee

Mayo Clinic

Blood Advances | October 31, 2019 | Volume: 3 | Issue: 21 | Pages: 3278-3286

10.1182/bloodadvances.2019000569 | PMID 31698456 Get It

Key PointsClinical, research and mentorship experiences in hematology are positively associated with fellows' plans to pursue hematology-only careers.
Implications for Tumor Microenvironment and Epithelial Crosstalk in the Management of Gastrointestinal Cancers
Ge, Yang , Westphalen, C. Benedikt , Weygant, Nathaniel , Ma, Wen Wee, Weygant, Nathaniel , Wee, Wen , Vega, Kenneth J.

Mayo Clinic

Journal of Oncology | October 31, 2019 | Volume: 2019 | Issue: No issue available | Pages: 1-11

10.1155/2019/4835318 | PMID 32082375 Get It

Rapid advances in technology are revealing previously unknown organization, cooperation, and limitations within the population of nontumor cells surrounding the tumor epithelium known as the tumor microenvironment (TME). Nowhere are these findings more pertinent than in the gastrointestinal (GI) tract where exquisite cell specialization supports a complex microenvironmental niche characterized by rapid stemness-associated cell turnover, pathogen sensing, epithelial orchestration of immune signaling, and other facets that maintain the complex balance between homeostasis, inflammation, and disease. Here, we summarize and discuss select emerging concepts in the precancerous microenvironment, TME, and tumor epithelial-TME crosstalk as well as their implications for the management of GI cancers.
Ablation plus Transarterial Embolic Therapy for Hepatocellular Carcinoma Larger than 3 cm: Science, Evidence, and Future Directions
Lewis, Andrew R. , Padula, Carlos A. , McKinney, J. Mark , Toskich, Beau , Toskich, Beau B.

Mayo Clinic

Seminars in Interventional Radiology | October 31, 2019 | Volume: 36 | Issue: 04 | Pages: 303-309

10.1055/s-0039-1697641 | PMID 31680721 Get It

AbstractThermal ablation is widely regarded as definitive therapy for early-stage hepatocellular carcinoma, but its efficacy decreases in tumors greater than 3 cm. Extensive clinical studies have supported improved outcomes provided through combining transarterial embolic therapy with ablation in the treatment of larger tumors. This article will provide a survey of the science and data for combination therapy in both thermal and nonthermal ablation modalities, as well as describe emerging applications.
Cryoablation of Lung Metastases: Review of Recent Literature and Ablation Technique
Eiken, Patrick W. , Welch, Brian T.

Mayo Clinic

Seminars in Interventional Radiology | October 31, 2019 | Volume: 36 | Issue: 04 | Pages: 319-325

10.1055/s-0039-1697002 | PMID 31680723 Get It

AbstractThis article reviews the current indications for image-guided thermal ablation of pulmonary metastatic disease. It also summarizes data regarding the efficacy and complications of lung cryoablation and present techniques for performing lung cryoablation as informed by the recent literature.
Use of troponins in clinical practice: Evidence in favour of use of troponins in clinical practice
Collinson, Paul , Apple, Fred S. , Jaffe, Allan S. , Collinson, Paul O , Jaffe, Allan S.

Mayo Clinic

Heart | October 31, 2019 | Volume: 106 | Issue: 4 | Pages: 253-255

10.1136/heartjnl-2019-315622 | PMID 31672780 Get It

Molecular Breast Imaging in Patients with Suspicious Calcifications
Hunt, Katie N. , Johnson, Matthew P. , Conners, Amy Lynn , O’Connor, Michael K. , Rhodes, Deborah J. , Basappa, Susanna , Wahner‐Roedler, Dietlind L. , O'Connor, Michael K, Wahner-Roedler, Dietlind, Hruska, Carrie B.

Mayo Clinic

Journal of Breast Imaging | October 31, 2019 | Volume: 1 | Issue: 4 | Pages: 303-309

10.1093/jbi/wbz054 | PMID 38424809 Get It

AbstractObjectiveWe evaluated the accuracy of molecular breast imaging (MBI)—a nuclear medicine technique that employs dedicated dual-detector, cadmium zinc telluride gamma cameras to image the functional uptake of a radiopharmaceutical (typically Tc-99m sestamibi) in the breast—in patients with suspicious calcifications on mammography.MethodsWomen scheduled for stereotactic biopsy of calcifications detected on 2D digital mammography were prospectively enrolled to undergo MBI before biopsy. Molecular breast imaging was performed with injection of Tc-99m sestamibi and a dual-detector, cadmium zinc telluride gamma camera. Positive findings on either modality were biopsied. High-risk and malignant biopsy findings were excised.ResultsIn 71 participants, 76 areas of calcifications were recommended for biopsy after mammography, and 24 (32%) were malignant, including 20 cases of ductal carcinoma in situ (DCIS) and 4 cases of invasive ductal cancer. Prebiopsy MBI was positive in 17 of the 76 (22%) calcifications, including 10 of 20 (50%) DCISs and 2 of 4 (50%) invasive cancers. The median pathologic size for MBI–positive cancers was 1.5 cm (range 0.5–3.2 cm) compared with 0.9 cm (range 0.1–2.0 cm) for MBI–negative cancers (P = 0.09).Non-mass uptake on MBI led to additional biopsies of 6 sites in 6 patients, and 2 of 6 (33%) MBI–detected incidental lesions showed malignancy; both DCIS contralateral to the mammographically detected calcifications. The overall per-lesion positive and negative predictive values of MBI in this prebiopsy setting were 61% (14 of 23) and 80% (47 of 59), respectively.ConclusionMolecular breast imaging has insufficient negative predictive value to identify calcifications in which biopsy could be avoided. However, among women presenting for biopsy of suspicious calcifications, MBI revealed additional sites of mammographically occult breast cancer.To avoid biopsy of suspicious calcifications on mammography, negative findings on MBI should not be used.
Evidence-based systematic review of cognitive rehabilitation, emotional, and family treatment studies for children with acquired brain injury literature: From 2006 to 2017
Laatsch, Linda, Dodd, Jonathan N., Brown, Tanya M. , Connor, Felicia, Davis, Kimberly C. , Doherty, Meghan , Linden, Mark , Locascio, Gianna , Murphy, Samantha , Nagele, Drew, Niemeier, Janet P. , Politis, Adam, Rode, Catrin, Slomine, Beth S. , Smetana, Racheal M. , Yaeger, Lauren , Brown, Tanya, Laatsch, Linda, Ciccia, Angela , Lundine, Jennifer P.

Mayo Clinic

Neuropsychological Rehabilitation | October 31, 2019 | Volume: 30 | Issue: 1 | Pages: 130-161

10.1080/09602011.2019.1678490 | PMID 31671014 Get It